Cardiovascular Surgery Department, Sant'Orsola-Malpighi Hospital, Bologna University, Bologna, Italy.
J Thorac Cardiovasc Surg. 2013 Feb;145(2):385-390.e1. doi: 10.1016/j.jtcvs.2012.01.042. Epub 2012 Feb 15.
Few data exist on clinical/imaging characteristics, management, and outcomes of patients with type A acute dissection and mesenteric malperfusion.
Patients with type A acute dissection enrolled in the International Registry for Acute Dissection (IRAD) were evaluated to assess differences in clinical features, management, and in-hospital outcomes according to the presence/absence of mesenteric malperfusion. A mortality model was used to identify predictors of in-hospital mortality in patients with mesenteric malperfusion.
Mesenteric malperfusion was detected in 68 (3.7%) of 1809 patients with type A acute dissection. Patients with mesenteric malperfusion were more likely to be older and to have coma, cerebrovascular accident, spinal cord ischemia, acute renal failure, limb ischemia, and any pulse deficit. They were less likely to undergo surgical/hybrid treatment (52.9% vs 87.9%) and more likely to receive only medical (30.9% vs 11.6%) or endovascular (16.2% vs 0.5%) management (P < .001). Overall in-hospital mortality was 63.2% and 23.8% in patients with and without mesenteric malperfusion, respectively (P < .001). In-hospital mortality of patients with mesenteric malperfusion receiving medical, endovascular, and surgical/hybrid therapy was 95.2%, 72.7%, and 41.7%, respectively (P < .001). At multivariate analysis, male gender (odds ratio [OR], 1.7; P = .002), age (OR, 1.1/y; P = .002), and renal failure (OR, 5.9; P = .020) were predictors of mortality whereas surgical/hybrid management (OR, 0.1; P = .005) was associated with better outcome.
Type A acute aortic dissection complicated by mesenteric malperfusion is a rare but ominous complication carrying a high risk of hospital mortality. Surgical/hybrid therapy, although associated with 2-fold hospital mortality, appears to be associated with better long-term outcomes in the management of type A acute aortic dissection in this setting.
关于伴有肠系膜动脉缺血的 A 型急性主动脉夹层的临床/影像学特征、处理方法和预后,目前仅有少量数据。
对国际急性主动脉夹层注册研究(IRAD)中纳入的 A 型急性主动脉夹层患者进行评估,以评估根据肠系膜动脉缺血的存在与否,在临床特征、处理方法和住院期间结局方面的差异。采用死亡率模型来确定伴有肠系膜动脉缺血的患者住院期间死亡的预测因素。
在 1809 例 A 型急性主动脉夹层患者中,发现肠系膜动脉缺血 68 例(3.7%)。伴有肠系膜动脉缺血的患者年龄更大,更有可能出现昏迷、脑血管意外、脊髓缺血、急性肾衰竭、肢体缺血和任何脉搏缺失。他们更有可能仅接受药物(30.9% vs 11.6%)或血管内(16.2% vs 0.5%)治疗(52.9% vs 87.9%),而不太可能接受手术/杂交治疗(P <.001)。伴有和不伴有肠系膜动脉缺血的患者的住院期间总死亡率分别为 63.2%和 23.8%(P <.001)。肠系膜动脉缺血患者接受药物、血管内和手术/杂交治疗的院内死亡率分别为 95.2%、72.7%和 41.7%(P <.001)。多变量分析显示,男性(比值比[OR],1.7;P =.002)、年龄(OR,1.1/岁;P =.002)和肾衰竭(OR,5.9;P =.020)是死亡的预测因素,而手术/杂交治疗(OR,0.1;P =.005)与更好的结局相关。
伴有肠系膜动脉缺血的 A 型急性主动脉夹层是一种罕见但凶险的并发症,具有很高的住院死亡率风险。尽管手术/杂交治疗与 2 倍的住院死亡率相关,但在这种情况下,它似乎与 A 型急性主动脉夹层的长期管理结果更好相关。